AgraFlora Accepts Resignation of Director to Facilitate Transition of its Corporate Strategy

Press Release

Vancouver British Columbia / March 10, 2021 – AgraFlora Organics International Inc. (“AgraFlora” or the “Company”) (CSE: AGRA) (Frankfurt: PU31) (OTCPK: AGFAF) is pleased to announce that it has recently accepted the resignation of Christopher (Chris) Hornung from the Company’s board of directors. Mr. Hornung’s amicable resignation facilitates the expected appointment of a new director to the Company’s board in the near future and is aligned with the recent appointment of Elise Coppens as AgraFlora’s new Chief Executive Officer (“CEO”) and Director to implement the next phase of the Company’s corporate strategy.

The directorship vacancy created by Mr. Hornung’s resignation shall remain unoccupied until such a time as the Company has completed the search to fill the role. “I would like to thank Chris for his tenure on the board of directors and his dedication to AgraFlora over that time. We wish him well in his future endeavours and appreciate his professionalism throughout the transition process,” said Elise Coppens, CEO and Director of AgraFlora. “As we continue to reshape the organization for the future, the board and I are excited to have discussions with potential candidates, multiple of which have already been identified,” added Ms. Coppens.
About AgraFlora Organics International Inc.

AgraFlora Organics International Inc. is a leading cannabis company building shareholder value through the development of revenue generating operating assets in the global cannabis industry. AgraFlora is focused primarily on the Canadian cannabis industry – the world’s most advanced and regulated legal cannabis market. Flagship Canadian assets include: Edibles & Infusions, a fully automated manufacturing facility in Winnipeg, MB for white-label and consumer-branded edibles production; Propagation Services Canada, a large-scale commercial greenhouse in Delta, BC focused on reshaping the Canadian flower market with high-potency, low-cost cannabis; and AAA Heidelberg, a craft-focused cannabis producer in London, ON. In addition, AgraFlora’s wholly-owned subsidiary, Farmako GmbH, is focused on becoming Europe’s leading distributor of medical cannabis. Farmako currently has active distribution operations in Germany and expects to commence active operations in the United Kingdom in 2021. For more information about AgraFlora, please visit agraflora.ca and its profile page on SEDAR at www.sedar.com.

ON BEHALF OF THE BOARD OF DIRECTORS

Nick Kuzyk, Investor Relations
E: ir@agraflora.ca
T: (800) 783-6056

For French inquiries:

Maricom Inc.
Remy Scalabrini
E: rs@maricom.ca
T: (888) 585-MARI

IBF4